drugset / Trial / NCT02084771

Oral Salt and Water to Prevent Contrast Nephropathy

NCT02084771

RandomizedParallel-groupSingle-blindPrevention

Summary

The purpose of this pilot trial is to determine the safety and feasibility of using oral salt and water loading compared to intravenous saline for the prevention of contrast-induced acute kidney injury in patients with chronic kidney disease receiving a contrast-enhanced CT scan.

Timeline

Start
2014-10
Primary completion
2015-12
Completion
2016-06

Drugs

EvaluationDrugModalityDoseRoute
Subject Salt and Water Unknown 0.1 g/kg Oral
Comparator sodium chloride Unknown Intravenous

Indications